Procept BioRobotics is a surgical robotics company based in San Jose, California. The company is dedicated to improving patient care by developing innovative solutions in the field of urology. It was announced that members of management will be presenting at the 44th Annual TD Cowen Health Care Conference in Boston. The presentation is scheduled for Tuesday, March 5 at 12:50 p.m. Eastern Time. Those interested can access a live webcast of the event, as well as an archived recording, on the “Investors” section of the company’s website.
Procept BioRobotics is focused on developing, manufacturing, and selling the AquaBeam Robotic System. This system is an advanced, image-guided, surgical robotic system designed for use in minimally invasive urologic surgery. The initial focus of this system is on treating benign prostatic hyperplasia (BPH), a common prostate disease affecting approximately 40 million men in the United States. The company aims to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms (LUTS) due to BPH, regardless of prostate size and shape or the surgeon’s experience. Procept BioRobotics has developed a substantial body of clinical evidence, including nine clinical studies and over 150 peer-reviewed publications, to support the benefits and clinical advantages of Aquablation therapy.
For those who are interested in learning more about this innovative system and the company’s advancements in urology, a live webcast and an archived recording of the presentation will be available for at least 90 days after the event.